Back to search
FDAFDA · Food and drugs·Recall number Z-2379-2021

Baxter prismaflex, HF 1000 PAES membrane, REF 107140 Used with Prismaflex or PrisMax control units for continuous fluid management and renal replacement therapies.

Published September 8, 2021 · Recall initiated: July 22, 2021

Summary

FDA records medical device Class II recall Z-2379-2021, published September 8, 2021 and initiated July 22, 2021. Recalling firm: Baxter Healthcare Corporation; Status: Terminated; Reported quantity: 1976 units; Lot: Lot Numbers: 20B2330M. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Products labeled as sterile were distributed, but may not have been sterilized. Baxter confirmed Steril Milano observed nonconformances that were not reported to Baxter Data was manipulated to appear to be conforming

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Baxter Healthcare Corporation
Distributor
US Nationwide distribution.
Lot
Lot Numbers: 20B2330M
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Baxter prismaflex, HF 1000 PAES membrane, REF 107140 Used with Prismaflex or PrisMax control units for continuous fluid management and renal replacement therapies. recalled?

Yes. FDA published recall Z-2379-2021 on September 8, 2021. Reported hazard: Products labeled as sterile were distributed, but may not have been sterilized. Baxter confirmed Steril Milano observed nonconformances that were not reported to Baxter Data was manipulated to appear to be conforming

What should I do if I have this product?

Voluntary: Firm initiated · Letter